Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2
Open Access
- 11 July 2022
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 6 (13) , 4031-4040
Abstract
Von Willebrand disease (VWD) type 2 is caused by qualitative abnormalities of von Willebrand factor (VWF). This study aimed to determine the genotypic and phenotypic characterizations of a large VWD type 2 cohort from Milan. We included 321 patients (54% female) within 148 unrelated families from 1995 to 2021. Patients were fully characterized using laboratory phenotypic tests, and the genotypic diagnosis was confirmed by target genetic analysis using Sanger sequencing. Patients were diagnosed with type 2A (n = 98; 48 families), 2B (n = 85; 38 families), 2M (n = 112; 50 families), or 2N (n = 26; 12 families). Eighty-two unique VWF variants, including 8 novel variants, were found. The potential pathogenic effect of novel variants was assessed by in silico analysis. Most patients were heterozygous for a single variant (n = 259; 81%), whereas 37 cases (11%) had 2 variants (4 homozygous, 9 in trans, and 24 in cis). Twenty-five patients (8%) had ≥3 variants, mainly as a result of gene conversions. Among the 82 distinct variants identified, 5 different types, including missense (n = 64), gene conversion (n = 10), synonymous (n = 1), deletion (n = 4), and splice (n = 3), were observed. The results from this large cohort showed that VWD type 2 is invariably due to variants that do not prevent the synthesis of the protein, and a vast majority of patients (88%) had missense variants. Given the complexity of type 2 diagnosis and the necessity of performing several phenotypic tests, genetic analysis for patients suspected of having type 2 is beneficial to establish the correct diagnosis.Keywords
This publication has 57 references indexed in Scilit:
- Critical von Willebrand factor A1 domain residues influence type VI collagen bindingJournal of Thrombosis and Haemostasis, 2012
- Reduced von Willebrand factor secretion is associated with loss of Weibel–Palade body formationJournal of Thrombosis and Haemostasis, 2012
- Management of Inheritedvon Willebrand Disease in Italy: Results from the Retrospective Study on 1234 PatientsSeminars in Thrombosis and Hemostasis, 2011
- The International Society on Thrombosis and Haematosis von Willebrand Disease Database: An UpdateSeminars in Thrombosis and Hemostasis, 2011
- Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWDJournal of Thrombosis and Haemostasis, 2010
- Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decayHaematologica, 2009
- Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort studyJournal of Thrombosis and Haemostasis, 2007
- The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort studyBlood, 2007
- von Willebrand disease R1374C: Type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia)American Journal of Hematology, 2005
- Prevalence of von Willebrand disease in children: A multiethnic studyThe Journal of Pediatrics, 1993